Company Information

CIN
Status
Date of Incorporation
16 July 2015
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2022
Paid Up Capital
149,960,600
Authorised Capital
150,000,000

Directors

Pratap Reddy Linga Reddy Gaddam
Pratap Reddy Linga Reddy Gaddam
Director/Designated Partner
over 2 years ago
Kesava Reddy Madana
Kesava Reddy Madana
Director
about 3 years ago
Prashant Garg
Prashant Garg
Director/Designated Partner
over 3 years ago
Madhusudan Reddy Padira
Madhusudan Reddy Padira
Director/Designated Partner
over 10 years ago
Ravindra Nandlal Purohit
Ravindra Nandlal Purohit
Director
over 10 years ago

Patents

Process For The Preparation Of 21 Hydroxypregna 1, 4, 9(11), 16 Tetraene 3, 20 Dione 21 Acetate From Prednisolone

Provided herein is a shorter route of synthesis of 21-Hydroxypregna-1, 4, 9(11), 16-tetraene-3, 20-dione 21-acetate from Prednisolone that gives higher yield and better purity maintaining the regiospecificity of 21-Hydroxypregna-1,4,9(11),16-tetraene-3,20-dione 21-acetate.

Registered Trademarks

Vamdpi Vamsi Pharma

[Class : 5] Pharmaceutical Preparation For Pulmonary Disorder

Fbtune Vamsi Pharma

[Class : 5] Pharmaceutical Preparation For Pulmonary Disorder

Salflute Vamsi Pharma

[Class : 5] Pharmaceutical Preparation For Pulmonary Disorder
View +3 more Brands for Vamsi Pharma Private Limited.

Charges

16 Crore
01 October 2016
State Bank Of India
16 Crore
30 November 2015
Reliance Capital Ltd
2 Crore
01 October 2016
State Bank Of India
0
30 November 2015
Reliance Capital Ltd
0
01 October 2016
State Bank Of India
0
30 November 2015
Reliance Capital Ltd
0